The second Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of Helicobacter pylori infection in adult patients in Ireland

克拉霉素 医学 幽门螺杆菌 甲硝唑 左氧氟沙星 阿莫西林 内科学 利福平 质子抑制剂泵 抗生素耐药性 胃肠病学 重症监护医学 抗生素 微生物学 生物
作者
Sinéad M. Smith,Breida Boyle,Martin Buckley,Conor Costigan,Maeve Doyle,Richard J. Farrell,Mohd Syafiq Ismail,David Kevans,Sean G. Nugent,Anthony O’Connor,C O'Morain,Vikrant Parihar,Cristín Ryan,Deirdre McNamara
出处
期刊:European Journal of Gastroenterology & Hepatology [Lippincott Williams & Wilkins]
卷期号:36 (8): 1000-1009 被引量:5
标识
DOI:10.1097/meg.0000000000002796
摘要

Background There has been an increase in resistance to many of the antimicrobials used to treat Helicobacter pylori ( H. pylori ) nationally and internationally. Primary clarithromycin resistance and dual clarithromycin and metronidazole resistance are high in Ireland. These trends call for an evaluation of best-practice management strategies. Objective The objective of this study was to revise the recommendations for the management of H. pylori infection in adult patients in the Irish healthcare setting. Methods The Irish H. pylori working group (IHPWG) was established in 2016 and reconvened in 2023 to evaluate the most up-to-date literature on H. pylori diagnosis, eradication rates and antimicrobial resistance. The ‘GRADE’ approach was then used to rate the quality of available evidence and grade the resulting recommendations. Results The Irish H. pylori working group agreed on 14 consensus statements. Key recommendations include (1) routine antimicrobial susceptibility testing to guide therapy is no longer recommended other than for clarithromycin susceptibility testing for first-line treatment (statements 6 and 9), (2) clarithromycin triple therapy should only be prescribed as first-line therapy in cases where clarithromycin susceptibility has been confirmed (statement 9), (3) bismuth quadruple therapy (proton pump inhibitor, bismuth, metronidazole, tetracycline) is the recommended first-line therapy if clarithromycin resistance is unknown or confirmed (statement 10), (4) bismuth quadruple therapy with a proton pump inhibitor, levofloxacin and amoxicillin is the recommended second-line treatment (statement 11) and (5) rifabutin amoxicillin triple therapy is the recommend rescue therapy (statement 12). Conclusion These recommendations are intended to provide the most relevant current best-practice guidelines for the management of H. pylori infection in adults in Ireland.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
heyuan1001完成签到,获得积分10
刚刚
SciGPT应助紧张的惜梦采纳,获得20
1秒前
1秒前
阿里嘎都完成签到,获得积分10
1秒前
深情不弱完成签到 ,获得积分10
1秒前
2秒前
2秒前
3秒前
ii完成签到,获得积分10
3秒前
HWX发布了新的文献求助10
3秒前
ddc_0819完成签到,获得积分10
3秒前
量子星尘发布了新的文献求助10
5秒前
852应助wanmiao12采纳,获得10
7秒前
8秒前
FashionBoy应助jzt12138采纳,获得10
8秒前
发嗲的雨筠完成签到,获得积分10
9秒前
暮然完成签到,获得积分10
9秒前
馆长应助ddc_0819采纳,获得10
9秒前
9秒前
9秒前
小陈完成签到,获得积分10
10秒前
叮当的猫完成签到,获得积分10
10秒前
独孤刘完成签到,获得积分10
10秒前
生动大白菜真实的钥匙完成签到,获得积分10
10秒前
lhc完成签到,获得积分10
11秒前
13秒前
单纯的曼文完成签到,获得积分10
13秒前
13秒前
14秒前
14秒前
Orange应助totolo采纳,获得10
14秒前
庾稀发布了新的文献求助10
15秒前
任元元完成签到 ,获得积分10
16秒前
momo关注了科研通微信公众号
17秒前
JuinZhu发布了新的文献求助50
17秒前
17秒前
JamesPei应助可乐采纳,获得10
17秒前
17秒前
ssy发布了新的文献求助10
18秒前
南山无玫落完成签到 ,获得积分20
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Nuclear Fuel Behaviour under RIA Conditions 500
Sociologies et cosmopolitisme méthodologique 400
Why America Can't Retrench (And How it Might) 400
Another look at Archaeopteryx as the oldest bird 390
Optimization and Learning via Stochastic Gradient Search 300
Higher taxa of Basidiomycetes 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 催化作用 遗传学 冶金 电极 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 4679792
求助须知:如何正确求助?哪些是违规求助? 4056132
关于积分的说明 12542028
捐赠科研通 3750643
什么是DOI,文献DOI怎么找? 2071501
邀请新用户注册赠送积分活动 1100578
科研通“疑难数据库(出版商)”最低求助积分说明 980055